SCHEMBL1824980

SCHEMBL1824980

CC(=O)N[C@@H](Cc1cccc(OS(C)(=O)=O)c1)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 2/20 0.43
MAPT P10636 3/20 0.42
TDP1 Q9NUW8 3/20 0.42
POLB P06746 1/20 0.42
MMP1 P03956 1/20 0.42
MMP3 P08254 1/20 0.42
MMP9 P14780 1/20 0.42
MAOA P21397 1/20 0.41
ITGA4 P13612 2/20 0.40
ITGB7 P26010 2/20 0.40
CTSS P25774 3/20 0.40
CTSK P43235 3/20 0.40
CTSB P07858 2/20 0.40
KLK5 Q9Y337 1/20 0.40
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
FAAH O00519 1/20 0.39
CTSL P07711 1/20 0.39
NTSR1 P30989 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1825260 0.91 CTSS (0.49) MAPTTDP1POLBCTSSCTSK
SCHEMBL1826460 0.89 CA12 (0.47) TACR1POLB
SCHEMBL1823295 0.87 TACR1 (0.45) TACR1MAPTTDP1POLBMMP1
SCHEMBL1825869 0.86 SYK (0.49) CTSSCTSKCTSBCTSL
SCHEMBL1827669 0.86 TACR1 (0.50) TACR1TDP1POLBPPARGPPARA
SCHEMBL3579862 0.86 LY96 (0.44) TACR1MAPTTDP1POLBMMP1
SCHEMBL3579864 0.86 LY96 (0.44) TACR1MAPTTDP1POLBMMP1
SCHEMBL1826522 0.86 KLK5 (0.53) POLBCTSSCTSKCTSBKLK5
SCHEMBL1829023 0.86 P2RX7 (0.49) TACR1MAPTTDP1NTSR1NPSR1
SCHEMBL1827586 0.85 PLAU (0.46) TACR1MAPTPOLBPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 TACR1 1743/4885MAPT 4712/4885TDP1 4543/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 TACR1 2452/4885MAPT 2237/4885TDP1 4702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.